WO2001039725A3 - Drug preparations - Google Patents

Drug preparations Download PDF

Info

Publication number
WO2001039725A3
WO2001039725A3 PCT/US2000/041961 US0041961W WO0139725A3 WO 2001039725 A3 WO2001039725 A3 WO 2001039725A3 US 0041961 W US0041961 W US 0041961W WO 0139725 A3 WO0139725 A3 WO 0139725A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug preparations
compositions
preparations
drug
semisolid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/041961
Other languages
French (fr)
Other versions
WO2001039725A2 (en
Inventor
Alan Drizen
Michael Micalizzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAM Pharmaceutical Corp USA
Original Assignee
LAM Pharmaceutical Corp USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAM Pharmaceutical Corp USA filed Critical LAM Pharmaceutical Corp USA
Priority to AU45042/01A priority Critical patent/AU4504201A/en
Priority to CA002390841A priority patent/CA2390841A1/en
Priority to EP00992485A priority patent/EP1231897A2/en
Publication of WO2001039725A2 publication Critical patent/WO2001039725A2/en
Anticipated expiration legal-status Critical
Publication of WO2001039725A3 publication Critical patent/WO2001039725A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Semisolid, sustained-release drug delivery compositions based on hyaluronic acid and its salts, and more particularly to the manufacture and use of such compositions.
PCT/US2000/041961 1999-11-08 2000-11-08 Drug preparations Ceased WO2001039725A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU45042/01A AU4504201A (en) 1999-11-08 2000-11-08 Drug preparations
CA002390841A CA2390841A1 (en) 1999-11-08 2000-11-08 Drug preparations
EP00992485A EP1231897A2 (en) 1999-11-08 2000-11-08 Drug preparations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16414999P 1999-11-08 1999-11-08
US60/164,149 1999-11-08

Publications (2)

Publication Number Publication Date
WO2001039725A2 WO2001039725A2 (en) 2001-06-07
WO2001039725A3 true WO2001039725A3 (en) 2002-05-10

Family

ID=22593194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/041961 Ceased WO2001039725A2 (en) 1999-11-08 2000-11-08 Drug preparations

Country Status (4)

Country Link
EP (1) EP1231897A2 (en)
AU (1) AU4504201A (en)
CA (1) CA2390841A1 (en)
WO (1) WO2001039725A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972636B2 (en) 2004-02-25 2011-07-05 Hidemoto Kusaka Beverage and medicament containing bamboo extract as a main ingredient
EP1723854B1 (en) * 2004-02-25 2015-05-06 KUSAKA, Hidemoto Beverage or drug containing bamboo extract as main ingredient
EP2252262B1 (en) * 2008-01-18 2020-03-18 Dow Global Technologies LLC Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals

Also Published As

Publication number Publication date
AU4504201A (en) 2001-06-12
CA2390841A1 (en) 2001-06-07
WO2001039725A2 (en) 2001-06-07
EP1231897A2 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
WO2001032596A8 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
AU2274201A (en) Compounds and compositions for delivering active agents
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2000007979A3 (en) Compounds and compositions for delivering active agents
WO1999053910A8 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
WO2002100437A3 (en) Ophthalmic compositions comprising hyaluronic acid
MX9700885A (en) New heteroaryloxazolidinones.
IL148288A0 (en) Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ZA200106104B (en) Pharmaceutical composition containing proton pump inhibitors.
AU3850600A (en) Dalda analogs and their use
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
EP1391200A4 (en) DRUG PREPARATIONS
MXPA03007857A (en) Compounds and compositions for delivering active agents.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
WO2001039725A3 (en) Drug preparations
WO2001068676A3 (en) Lhrh-antagonists, production and use thereof as medicament
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
ZA200110244B (en) Novel xanthone compounds, their preparation and use as medicament.
AU6027899A (en) Local delivery of medications to the heart

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2390841

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000992485

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000992485

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000992485

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP